This session serves as a practical basic science review to discuss the historical use and the limitations of non-encapsulated BPO in comparison to encapsulated BPO. The clinical evidence for the use of encapsulated BPO in both acne and rosacea will be discussed.
- Review the historical use of unencapsulated BPO and the typical side effects noted with its use
- Differentiate unencapsulated and encapsulated BPO
- Discuss the clinical evidence for the use of encapsulated BPO in acne and rosacea
Disclosure of Conflicts of Interest
Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Neal Bhatia, MD||
Grants/Research Support: Abbvie, Aclaris, Almirall, Biofrontera, BMS, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Mayne, Menlo, Novartis, Ortho, Pfizer, Pierre-Fabre, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, Vidac, and Vyome Consulting Fees: Abbvie, Aclaris, Almirall, Biofrontera, BMS, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Mayne, Menlo, Novartis, Ortho, Pfizer, Pierre-Fabre, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, Vidac, and Vyome
|Name of Editor / Scientific Reviewer||Reported Financial Relationship|
|Raja Sivamani, MD MS AP||
Grants/Research Support: Regeneron Pharmaceuticals, Abbvie, Physicians Exclusive, Sytheon, Type A Deodorant Ownership Interest/Stock Holder: LearnHealth - Spouse Consultant: Regeneron Pharmaceuticals, Burt's Bees, Arbonne, Abbvie
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Content Manager||Reported Financial Relationship|
|Maria Mas, Planner||No relationships with a commercial interest to disclose|
|Planners at Your CE Source||No relationships with a commercial interest to disclose|
All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and LearnHealth. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians.
Your CE Source designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CE activity provides 1 contact hour of continuing nursing education. Your CE Source is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031.
Method of Participation